Related Experiment Video
Updated: Aug 4, 2025

06:04
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
934
Attack phenotypes and disease course in pediatric MOGAD.
Jonathan D Santoro1,2, Timothy Beukelman3, Cheryl Hemingway4
1Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
Annals of Clinical and Translational Neurology
|March 31, 2023
Summary
Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) often presents as acute disseminated encephalomyelitis in young children. About a quarter of pediatric MOGAD cases experience relapses, frequently involving optic neuritis.
Area of Science:
- Neuroimmunology
- Pediatric Neurology
- Demyelinating Diseases
Background:
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disorder targeting the central nervous system.
- Pediatric MOGAD exhibits distinct clinical characteristics compared to adult presentations.
Purpose of the Study:
- To review the literature on the presentation and clinical course of MOGAD specifically in children.
- To identify common initial phenotypes and relapse patterns in pediatric MOGAD.
Main Methods:
- A comprehensive literature review was conducted.
- Studies focusing on pediatric MOGAD cases were analyzed for clinical presentation and disease course.
Main Results:
- The most frequent initial presentation in children, particularly those under five, is acute disseminated encephalomyelitis.
- Optic neuritis and/or transverse myelitis are also common initial or subsequent manifestations.
- Approximately 25% of pediatric patients experience at least one relapse within three years, often involving optic neuritis.
Conclusions:
- Pediatric MOGAD has a varied presentation, with acute disseminated encephalomyelitis being prominent in younger children.
- Relapses are common in pediatric MOGAD, highlighting the need for long-term monitoring.
- Further research is needed to identify clinical risk factors for a relapsing disease course in children.

